PK-PD integration and modeling of marbofloxacin in sheep

Research in Veterinary Science

Volumn 88, Issue 1, 2010, Pages 134-141

  Sidhu, P K ^a   Landoni, M F ^b   Aliabadi, F S ^c   Lees, P ^d  

^a GURU ANGAD DEV VETERINARY AND ANIMAL SCIENCES UNIVERSITY   (India)

^b FACULTAD DE CIENCIAS VETERINARIAS   (Argentina)

^c Food Quality Control Laboratory   (Iran)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Dosage selection; Marbofloxacin; Pharmacokinetic pharmacodynamic integration; PK PD modeling; Sheep

Indexed keywords

MARBOFLOXACIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; EX VIVO STUDY; EXUDATE; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MANNHEIMIA HAEMOLYTICA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SHEEP;

ANIMALS; ANTI-INFECTIVE AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROQUINOLONES; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MANNHEIMIA HAEMOLYTICA; METABOLIC CLEARANCE RATE; MICROBIAL SENSITIVITY TESTS; PASTEURELLACEAE INFECTIONS; SHEEP; SHEEP DISEASES;

MANNHEIMIA HAEMOLYTICA; OVIS ARIES;

EID: 71949130656     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.05.013     Document Type: Article

References (34)

1. Aliabadi F.S., and Lees P. Pharmacokinetics and pharmacodynamics of danofloxacin in serum and tissue fluids of goats following intravenous and intramuscular administration. American Journal of Veterinary Research 62 (2001) 1979-1989
2. Aliabadi F.S., and Lees P. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate. Journal of Veterinary Pharmacology and Therapeutics 25 (2002) 161-174
3. Aliabadi F.S., and Lees P. Pharmacokinetic-pharmacodynamic integration of danofloxacin in the calf. Research in Veterinary Science 74 (2003) 247-259
4. Aliabadi F.S., Landoni M.F., and Lees P. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of danofloxacin in sheep biological fluids. Antimicrobial Agents and Chemotherapy 47 (2003) 626-635
5. Appelbaum P.C., and Hunter P.A. The fluoroquinolone antibacterials: past, present and future perspectives. International Journal of Antimicrobial Agents 16 (2000) 5-15
6. Bidgood T.L., and Papich M.G. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. Journal of Veterinary Pharmacology and Therapeutics 28 (2005) 329-341
7. Clarke C.R. Tissue-chambers modeling systems-applications in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 12 (1989) 349-368
8. Dova S.W., San Andres M.D., Gonzalez F., San Andres M.I., De Lucas J.J., and Rodriquez C. Pharmacokinetic behaviour and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats. The Veterinary Journal (2006)
9. Drusano G.L. Prevention of resistance. A goal for dose selection for antimicrobial agents. Clinical Infectious Diseases 36 Suppl. 1 (2003) S42-50
10. Fabrega A., Sanches-Cespedes J.S., Soto S., and Vila J. Quinolone resistance in the food chain. International Journal of Antimicrobial Agents 31 (2008) 307-315
11. Guyonnet J., Monnoyer S., Manco B., Aliabadi F.S., and Lees P. In vivo pharmacokinetics and in vitro pharmacodynamics as a basis for predicting dosage of colistin in piglet g.i.t. disease. Journal of Veterinary Pharmacology, and Therapeutics 26 Suppl. 1 (2003) 148-149
12. Hannan P.C.T., O'Hanlon P.J., and Rogers N.H. In vitro evaluation of various quinolone antibacterial agents against veterinary mycoplasmas and porcine respiratory bacterial pathogens. Research in Veterinary Science 46 (1989) 202-211
13. Haritova A.M., Rusenova N.V., Parvanov P.R., Lashev L.D., and Fink-Gremmels J. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys. Antimicrobial Agents and Chemotherapy 50 (2006) 3779-3785
14. Higgins A.J., Lees P., and Wright J.A. Tissue-cage model for collection of inflammatory exudate in ponies. Research in Veterinary Science 36 (1984) 284-289
15. Ismail M., and El-Kattan Y.A. Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves. Research in Veterinary Science 82 (2007) 398-404
16. Lees P., Aliabadi F.S., and Toutain P.L. PK-PD modelling: an alternative to dose titration studies for antimicrobial drug dosage selection. Journal of Regulatory Affairs 15 (2004) 175-180
17. Lees P., Concordet D., Aliabadi F.S., and Toutain P.L. Drug selection and optimization of dosage schedules to minimize antimicrobial resistance. In: Aarestrup F.M. (Ed). Antimicrobial Resistance in Bacteria of Animal Origin (2006), ASM Press, Washington, DC, USA (Chapter 5)
18. Mouton J.W., Dudley M.N., Cars O., Derendorf H., and Drusano G.L. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs. International Journal of Antimicrobial Agents 19 (2002) 355-358
19. Olofsson S.K., Marcusson L.L., Strömbäck A., Hughes D., and Cars O. Dose-related selection of fluoroquinolone-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy 60 (2007) 795-801
20. Perrier D., and Mayersohn M. Noncompartmental determination of the steady-state volume of distribution for any mode of administration. Journal of Pharmaceutical Sciences 71 (1982) 372-373
21. Petracca K., Riond J.L., Graser T., and Wanner M. Pharmacokinetics of the gyrase inhibitor marbofloxacin: influence of pregnancy and lactation in sows. Journal of Veterinary Medicine A 40 (1993) 73-79
22. Peyrou M., Doucet M.Y., Vrins A., Concordet D., Schneider M., and Bousquet-Melou A. Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 282-288
23. Sidhu P.K., Aliabadi F.S., Andrews M., and Lees P. Tissue chamber model of acute inflammation in farm animal species. Research in Veterinary Science 74 (2003) 67-77
24. Sidhu, P.K., Landoni, M.F., Aliabadi, F.S., Lees, P., in press. Pharmacokinetic and pharmacodynamic modeling of marbofloxacin administered alone and in combination with tolfenamic acid in goats. The Veterinary Journal.
25. Spreng M., Deleforge J., Thomas V., Boisrame B., and Drugeon H. Antibacterial activity of marbofloxacin: a new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics 18 (1995) 284-289
26. Thomas E., Caldow G.L., Borell D., and Davot J.L. A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics 24 (2001) 353-358
27. Toutain P.L. Pharmacokinetics/pharmacodynamics integration in dosage regimen optimisation for veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 26 Suppl. 1 (2003) 1-8
28. Toutain P.L. Antibiotic treatment of animals - a different approach to rational dosing. The Veterinary Journal 165 (2003) 98-100
29. Toutain P.L. Integration and modelling of pharmacokinetic and pharmacodynamic data to optimise dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 467-477
30. Toutain P.L., and Bousquet-Melou A. Plasma clearance. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 415-425
31. Toutain P.L., and Bousquet-Melou A. Volumes of distribution. Journal of Veterinary Pharmacology and Therapeutics 27 (2004) 441-453
32. Voermans M., Van Soest J.M., Van Duijkeren E., and Ensink J.M. Clinical efficacy of intravenous administration of marbofloxacin in a Staphylococcus aureus infection in tissue cages in ponies. Journal of Veterinary Pharmacology and Therapeutics 29 (2006) 555-560
33. Waxman S., San Andres M.D., Gonzalez F., De Lucas J.J., San Andres M.I., and Rodriguez C. Influence of Escherichia coli endotoxin-induced fever on the pharmacokinetic behaviour of marbofloxacin after intravenous administration in goats. Journal of Veterinary Pharmacology and Therapeutics 26 (2003) 65-69
34. Wolfson J.S., and Hooper D.C. Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews 2 (1989) 378-424